Whedon Cancer Foundation is categorized under Research and Development Laboratories in Sheridan, WY and active since 1954.
Whedon Cancer Foundation was established in 1954, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Dr Michael Hiller at the company’s single location by writing to 30 South Scott St, Sheridan, Wyoming WY 82801 or by phoning (307) 672-2941. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Whedon Cancer Foundation |
| Contact Person: | Dr Michael Hiller |
| Address: | 30 South Scott St, Sheridan, Wyoming 82801 |
| Phone Number: | (307) 672-2941 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1954 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Whedon Cancer Foundation was started in 1954 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Dr Michael Hiller for inquiries that concern Whedon Cancer Foundation by calling the company number (307) 672-2941, as your correspondence is most welcome. Additionally, the physical location of the single location of Whedon Cancer Foundation can be found at the coordinates as well as the street address 30 South Scott St in Sheridan, Wyoming 82801.
For its online presence, you may visit Whedon Cancer Foundation’s website at and engage with its social media outlets through on Twitter and on Facebook.